TWO SIGMA ADVISERS, LP - HEPION PHARMACEUTICALS INC ownership

HEPION PHARMACEUTICALS INC's ticker is HEPA and the CUSIP is 426897104. A total of 43 filers reported holding HEPION PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.39 and the average weighting 0.0%.

Quarter-by-quarter ownership
TWO SIGMA ADVISERS, LP ownership history of HEPION PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2023$20,111
+158.6%
25,9000.0%0.00%
Q4 2022$7,778
-48.1%
25,900
-14.0%
0.00%
Q3 2022$15,000
-42.3%
30,100
-34.3%
0.00%
Q2 2022$26,000
-75.5%
45,800
-44.1%
0.00%
Q1 2022$106,000
-12.4%
81,900
-23.1%
0.00%
Q4 2021$121,000
-35.6%
106,500
-13.4%
0.00%
Q3 2021$188,000
-89.1%
123,000
-85.9%
0.00%
-100.0%
Q2 2021$1,725,000
+659.9%
871,200
+606.6%
0.01%
+400.0%
Q1 2021$227,000123,3000.00%
Other shareholders
HEPION PHARMACEUTICALS INC shareholders Q3 2021
NameSharesValueWeighting ↓
SABBY MANAGEMENT, LLC 57,309$178,0000.03%
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC 15,552$48,0000.00%
Squarepoint Ops LLC 15,524$48,0000.00%
ExodusPoint Capital Management, LP 11,632$36,0000.00%
BANK OF AMERICA CORP /DE/ 33,215$103,0000.00%
WELLS FARGO & COMPANY/MN 57$00.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 15,786$49,0000.00%
MILLENNIUM MANAGEMENT LLC 29,233$91,0000.00%
MORGAN STANLEY 54$00.00%
View complete list of HEPION PHARMACEUTICALS INC shareholders